
Climate Change Will Boost Viral Outbreaks
A modeling study is the first to project how global warming will increase animal encounters and virus swapping between species

Climate Change Will Boost Viral Outbreaks
A modeling study is the first to project how global warming will increase animal encounters and virus swapping between species

Here’s Who Should Get a Second COVID Booster
An individual’s health risks, treatment access and local case levels come into play for those who are eligible

Sign up now to get 60 days of digital access

How to Judge COVID Risks and When to Wear a Mask
Scientific American asks experts in medicine, risk assessment and other fields how to balance the risks of COVID with the benefits of visiting public indoor spaces

Are New Omicron Subvariants a Threat? How Scientists are Keeping Watch
In South Africa, a network of researchers are studying whether new lineages BA.4 and BA.5 escape immunity from COVID-19 vaccines and prior infections

Venturing Back to the Office and the Benefits of Hybrid Immunity: COVID Quickly, Episode 28
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.
You can listen to all past episodes here.

New Cases of Childhood Diabetes Rose during the Pandemic
It isn’t clear why, but researchers are investigating a possible COVID link

COVID Vaccines plus Infection Can Lead to Months of Immunity
New research counters high-profile claims that people who had COVID don’t benefit from vaccination

What We Know about Omicron’s BA.2 Variant So Far
Does the new strain sweeping the globe mean COVID will become ever more contagious?

Second Boosters, Masks in the Next Wave and Smart Risk Decisions: COVID Quickly, Episode 27
Today we bring you a new episode in our podcast series COVID, Quickly. Every two weeks, Scientific American’s senior health editors Tanya Lewis and Josh Fischman catch you up on the essential developments in the pandemic: from vaccines to new variants and everything in between.
You can listen to all past episodes here.

A Simple Solution Would Make COVID Antivirals More Accessible, Pharmacists Say
The Biden administration’s Test to Treat program aims to make the treatments available at pharmacies, yet it requires a medical provider to prescribe the drugs

What One Million COVID Dead Mean for the U.S.’s Future
The country has reached an unthinkably grim milestone. Nearly 200,000 children have lost parents, many more elderly have been killed, and family well-being has been ripped apart

Can Drugs Reduce the Risk of Long COVID? What Scientists Know So Far
Researchers are trying to establish whether existing COVID-19 vaccines and treatments can prevent lasting symptoms